AC Immune SA (ACIU)

NASDAQ: ACIU · Real-Time Price · USD

2.700

-0.190 (-6.57%)

Mar 27, 2026, 4:00 PM EDT - Market closed

Revenue by Segment

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Discovering and Developing Therapeutic and Diagnostic Products	3.57M	27.31M	14.80M	3.94M		15.43M
Discovering and Developing Therapeutic and Diagnostic Products Growth	-86.92%	84.51%	276.14%	-		-86.03%
Total	3.57M	27.31M	14.80M	3.94M		15.43M
Total Growth	-86.92%	84.51%	276.14%	-		-86.03%

Revenue by Geography

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Switzerland	3.57M	27.31M	14.80M	3.94M		15.43M
Switzerland Growth	-86.92%	84.51%	276.14%	-		-86.03%
Total	3.57M	27.31M	14.80M	3.94M		15.43M
Total Growth	-86.92%	84.51%	276.14%	-		-86.03%

Source: S&P Global Market Intelligence.